Phreesia, Inc. (NYSE:PHR) SVP Sells $344,995.20 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,616 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $29.70, for a total value of $344,995.20. Following the transaction, the senior vice president now owns 218,135 shares in the company, valued at $6,478,609.50. The trade was a 5.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

David Linetsky also recently made the following trade(s):

• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The stock was sold at an average price of $29.52, for a total value of $8,856.00.
• On Wednesday, February 5th, David Linetsky sold 720 shares of Phreesia stock. The shares were sold at an average price of $29.50, for a total value of $21,240.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The shares were sold at an average price of $29.68, for a total value of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total value of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total value of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The stock was sold at an average price of $24.85, for a total value of $294,547.05.

Phreesia Price Performance

Shares of Phreesia stock opened at $28.49 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.66 billion, a PE ratio of -19.38 and a beta of 0.96. The business’s 50-day moving average price is $27.22 and its 200-day moving average price is $23.80. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the company earned ($0.58) EPS. Sell-side analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on PHR. Robert W. Baird decreased their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Piper Sandler reaffirmed an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Thirteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $31.15.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Phreesia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock valued at $121,349,000 after acquiring an additional 61,048 shares during the period. Greenhouse Funds LLLP boosted its holdings in Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock valued at $72,307,000 after acquiring an additional 626,579 shares during the period. Champlain Investment Partners LLC boosted its holdings in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the period. Franklin Resources Inc. boosted its holdings in Phreesia by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock valued at $37,982,000 after acquiring an additional 11,986 shares during the period. Finally, State Street Corp boosted its holdings in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.